Navigation Links
Elekta to Demonstrate Latest MOSAIQ OIS Innovations for Oncology Practices at 2012 ASCO Annual Meeting
Date:5/30/2012

ATLANTA, May 30, 2012 /PRNewswire/ -- Advanced automation, sophisticated eScribe merge field capabilities and an American Cancer Society clinician portal are among the new innovations showcased in Elekta's MOSAIQ® Oncology Information System (OIS)  at the American Society of Clinical Oncology (ASCO) Annual Meeting, June 1-4, at McCormick Place in Chicago.

In addition, for the sixth consecutive year, Elekta (booth #4019) has been selected to demonstrate at ASCO's EHR Vendor Lab. The 2012 Lab will be a live, in-person resource held June 2-4 in the Oncology Professionals Hall, booth #5004.

MOSAIQ is designed to manage the complete spectrum of oncology treatments in a single patient record. For chemotherapy, MOSAIQ provides a clear, flexible way to chart the patient's treatment across the medical assessment and chemotherapy administration process.

New in MOSAIQ:

  • Clinicians can bring advanced automation to the oncology practice through MOSAIQ IQ Scripts, a tool that launches a customizable "script" of activities that connect to each other. For example, IQ Scripts might be used to generate a warning message or launch an assessment based on order approval or Quality Checklist (QCL) completion. The results are exceptional control, efficiency and customization across the entire oncology workflow.
  • Enhancements to eScribe Merge Fields are available, allowing the user to put clinical, insurance, and scheduling information about the patient in eScribe documents, including the ability to add new fields instantly from a new drag-and-drop interface.
  • Oncologists will be able to launch the American Cancer Society's Clinician Portal directly from MOSAIQ, allowing instant access to their library of patient resources.
  • Full featured and integrated Survivorship module, allowing physicians to create a patient-specific treatment summary with recommendations for treatment follow up, including support resources in the community, treatment summary and recommendations for follow-up care.

MOSAIQ is the first comprehensive, oncology-specific EMR certified for meaningful use under the federal government's American Recovery and Reinvestment Act. The latest version of MOSAIQ is optimized for practices planning to demonstrate meaningful use, which qualifies them to receive payments from the Centers for Medicare & Medicaid Services (CMS) under Medicare rules.

MOSAIQ ranked first in the 2011 Best in KLAS Awards: Software & Services report. KLAS's data also are supported by the U.S. News & World Report 2011-12 best hospital rankings, which indicate that 46 out of the 50 top-ranked cancer hospitals are users of Elekta's oncology software.

"Yearly, ASCO always attracts the top minds in oncology, and we're honored to support this event," says Todd Powell, Executive Vice President, Elekta Software. "We anticipate that visitors to the Elekta exhibit will see once again why MOSAIQ is the preferred OIS for thousands of oncology practices."

Learn more at www.elekta.com/mosaiq.

For further information, please contact:
Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37, email: stina.thorman@elekta.com
Time zone: CET: Central European Time

Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: michelle.joiner@elekta.com
Time zone: ET: Eastern Time

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.


'/>"/>
SOURCE Elekta
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Elekta Announces Clinical Start-Up of New Leksell Gamma Knife(R) Perfexion(TM) at UPMC
2. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
3. First Clinical Volumetric Modulated Arc Therapy Treatment Completed With Elekta Synergy(R) S at General Hospital Vienna
4. Elektas New Line of Stereotactic Treatment Solutions is Redefining Excellence in Stereotaxy, a Case at a Time
5. Seattles Swedish Cancer Institute First in U.S. to Treat Cancer Patient with Elekta VMAT
6. CMS, Inc., an Elekta Company, Announces First Cancer Patients Treated With Monaco(TM) Radiation Treatment Planning System
7. Massachusetts General Hospital Selects Elekta As New Vendor for Complete Cancer Treatment Solution
8. National Intrepid Center of Excellence To Combat Traumatic Brain Injury With Sophisticated Brain Mapping Technology From Elekta
9. Elekta Provides Complete Planning, Treatment and Workflow Solution for Roy and Patricia Disney Family Cancer Center
10. Elekta Demonstrates Continued Leadership in Image Guidance at 2009 ASTRO Annual Meeting
11. Elekta Expands Consultative Services Program to Help MOSAIQ Customers Demonstrate Meaningful Use Guidelines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , March 27, 2017 ... specialty clinical-stage pharmaceutical company specializing in the development of ... public offering in the United States ... each ADS representing 40 ordinary shares of the ... In addition, Therapix has granted the underwriters a ...
(Date:3/27/2017)...  Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ("Cryoport" or the ... of common stock in an underwritten public offering under ... Securities and Exchange Commission (the "SEC"). The offering is ... be no assurance as to whether or when the ... size or terms of the offering. Cryoport also expects ...
(Date:3/27/2017)... 2017 To mark the end of Save Your ... leader in digital imaging solutions, will showcase Canon eye care ... New York,s Jacob Javits Center from ... sponsored by the American Optometric Association, is observed annually in ... comprehensive eye exams. In recognition of this observance, Canon ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... City trips have soared 82% ... Trends Report). As travelers visit both urban destinations, they are faced with exploration ... exposure. In response, the outdoor industry has blurred the lines between fashion and ...
(Date:3/28/2017)... ... 2017 , ... Z-Medica, LLC, a leading developer and marketer ... will acquire QuikClot® Bleeding Control Kits® (BCK) to equip up to 1,000 schools ... by the American College of Surgeons, U.S. Department of Defense, Department of Homeland ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... Paul Yost, will begin serving as new board chair for Orange County health ... will serve the remainder of soon-to-be former chair Mark Refowitz’s term, which runs ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... health plans work, the Self-Funding Success website has recently developed and published an ... Health Plans ” was created based on common inquiries the site’s team of ...
(Date:3/28/2017)... ... March 28, 2017 , ... Prominant bariatric surgeon and ... thrilled to offer the recently FDA-approved Obalon Balloon System to his patients. The ... Advanced Surgical’s already comprehensive list of weight-loss services. Dr. Liu is proud ...
Breaking Medicine News(10 mins):